P/E ratio for Torrent Pharmaceuticals (TORNTPHARM.NS)
P/E ratio as of April 2024 (TTM): 63.4
According to Torrent Pharmaceuticals 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 63.3786. At the end of 2022 the company had a P/E ratio of 63.7.
P/E ratio history for Torrent Pharmaceuticals from 2012 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 63.7 | 40.03% |
| 2021 | 45.5 | 19.1% |
| 2020 | 38.2 | -31.75% |
| 2019 | 56.0 | 52.53% |
| 2018 | 36.7 | 2.09% |
| 2017 | 35.9 | 63.22% |
| 2016 | 22.0 | 41.53% |
| 2015 | 15.6 | -29.66% |
| 2014 | 22.1 | 46.93% |
| 2013 | 15.1 | -21.48% |
| 2012 | 19.2 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.